Comparing clinical outcomes in patients with type 2 diabetes mellitus after ischaemic stroke: Sodium–glucose cotransporter 2 inhibitors users versus non‐users. A propensity score matching National Cohort Study.

MLA

Chen, Tzu‐Yang, et al. “Comparing Clinical Outcomes in Patients with Type 2 Diabetes Mellitus after Ischaemic Stroke: Sodium–glucose Cotransporter 2 Inhibitors Users versus Non‐users. A Propensity Score Matching National Cohort Study.” Diabetes, Obesity & Metabolism, vol. 26, no. 10, Oct. 2024, pp. 4501–09. EBSCOhost, https://doi.org/10.1111/dom.15804.

APA

Chen, T., Lee, H., Chan, Y., Chuang, C., Li, P., Yeh, Y., Su, H., & See, L. (2024). Comparing clinical outcomes in patients with type 2 diabetes mellitus after ischaemic stroke: Sodium–glucose cotransporter 2 inhibitors users versus non‐users. A propensity score matching National Cohort Study. Diabetes, Obesity & Metabolism, 26(10), 4501–4509. https://doi.org/10.1111/dom.15804

Chicago

Chen, Tzu‐Yang, Hsin‐Fu Lee, Yi‐Hsin Chan, Chi Chuang, Pei‐Ru Li, Yung‐Hsin Yeh, Hung‐Chi Su, and Lai‐Chu See. 2024. “Comparing Clinical Outcomes in Patients with Type 2 Diabetes Mellitus after Ischaemic Stroke: Sodium–glucose Cotransporter 2 Inhibitors Users versus Non‐users. A Propensity Score Matching National Cohort Study.” Diabetes, Obesity & Metabolism 26 (10): 4501–9. doi:10.1111/dom.15804.